The Hepatitis Fund (EndHep2030) is the grant-making organization dedicated to the mission of ending viral hepatitis. By funding a variety of the most effective interventions, the Fund intends to overcome the barriers that prevent countries from properly addressing viral hepatitis — a pandemic that kills 1.4 million people per year. It delivers catalytic funding to spark the elimination of viral hepatitis in resource limited settings by the end of 2030.